NewGen BioPharma Corp. Retained Earnings
NewGen BioPharma Corp. had Retained Earnings of -$344.02 thousand as of 2017-01-31, per its 10-Q filed 2017-03-09.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2017-03-09
- 2017-01-31: Retained Earnings (Accumulated Deficit) -$344.02K.
- 2016-10-31: Retained Earnings (Accumulated Deficit) -$190.55K.
- 2016-07-31: Retained Earnings (Accumulated Deficit) -$170.01K.
- 2016-04-30: Retained Earnings (Accumulated Deficit) -$166.01K.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2017-01-31 | -$344.02K 10-Q · filed 2017-03-09 |
| 2016-10-31 | -$190.55K 10-Q · filed 2017-03-09 |
| 2016-07-31 | -$170.01K 10-Q · filed 2016-09-07 |
| 2016-04-30 | -$166.01K 10-Q · filed 2016-06-14 |
| 2016-01-31 | -$159.97K 10-Q · filed 2016-03-16 |
| 2015-10-31 | -$148.68K 10-K · filed 2017-01-25 |
| 2015-07-31 | -$135.25K 10-Q · filed 2015-09-10 |
| 2015-04-30 | -$130.85K 10-Q · filed 2015-06-15 |
| 2014-10-31 | -$115.29K 10-K · filed 2016-01-28 |